Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcichew D3 Absorption Study
NCT02338713Phase 1Completed
- Sponsor
- Takeda
- Start
- Jan 2015
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of calcium carbonate + cholecalciferol in osteoporosis, Hypocalcemia and Vitamin D deficiency (VDD), sponsored by Takeda. Primary endpoints: Area Under the Serum Concentration-Time Curve for Parathyroid Hormone and Amount of Calcium Excreted in Urine. Started Jan 2015; status: completed.
02
Drugs
calcium carbonate + cholecalciferol
03
Conditions
osteoporosisHypocalcemiaVitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT02338713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338713.